Transform Patient
Care Through Early
LS Intervention
Early detection is key to effectively managing Lynch syndrome and reducing the risk of associated cancers.
By utilizing DiagMMMR testing, healthcare providers can identify at-risk individuals early on, allowing for timely intervention, proactive surveillance and personalized risk management strategies.
Advanced Lynch syndrome diagnostics for your patients
DiagMMR represents a significant advancement in Lynch syndrome diagnostics, offering healthcare providers a powerful tool to improve patient care and outcomes. By harnessing the precision and accuracy of DiagMMR, healthcare providers can identify at-risk individuals, implement preventive measures, and ultimately, save lives.
Minimally invasive
DiagMMR is a functional test designed to detect mismatch repair (MMR) deficiency from a minimally invasive, non-malignant tissue sample – before tumors appear. Unlike traditional methods, DiagMMR testing is performed directly on patient cells, allowing for accurate detection without the need to know the underlying variant.
Actionable results
DiagMMR offers healthcare providers a proactive approach to Lynch syndrome testing, enabling early detection and intervention before tumors develop. By analyzing proteins extracted from patient cells, DiagMMR provides actionable results that empower patients and families to take their next steps faster.
Accelerate diagnoses
While DNA sequencing may return results faster, interpretations can often take 6-8 weeks or more. In contrast, DiagMMR test results are available in just 3-4 weeks and do not require interpretation.
Empower patients
By incorporating DiagMMR into clinical practices, healthcare providers can enhance patient care, streamline diagnostic workflows, and ultimately, improve outcomes for individuals at risk of Lynch syndrome.
Patented in 29 countries
Canada
United States
Brazil
Europe
China
Japan
Australia
Lynch syndrome research
FAQs
for healthcare providers
How does DiagMMR testing differ from traditional Lynch syndrome testing methods?
DiagMMR testing directly identifies mismatch repair (MMR) deficiency from patient cells, delivering actionable results without necessitating knowledge of the underlying genetic variant. In contrast to conventional DNA sequencing methods, DiagMMR provides rapid turnaround times and eliminates the need for extensive interpretation processes.
What types of tissue samples are suitable for DiagMMR testing, and how is the testing process performed?
DiagMMR testing is performed on minimally invasive, non-malignant tissue samples from forearm skin. The testing process involves analyzing proteins extracted from patient cells to detect MMR deficiency, enabling early detection of Lynch syndrome before tumors appear.
How accurate and reliable is DiagMMR testing in detecting Lynch syndrome?
DiagMMR testing has been clinically validated and demonstrates high accuracy and reliability in detecting MMR deficiency associated with Lynch syndrome. With its functional approach and rigorous quality control measures, DiagMMR offers healthcare providers confidence in the accuracy of test results.
How can healthcare providers integrate DiagMMR testing into their clinical practice, and what are the benefits for their patients?
Healthcare providers can easily integrate DiagMMR testing into their clinical practice. The benefits for patients include timely access to actionable results, proactive management strategies, and improved outcomes through early detection and intervention.
Are there any specific patient populations or clinical scenarios where DiagMMR testing is particularly beneficial?
DiagMMR testing is beneficial for patients with a family history of Lynch syndrome or individuals with suspected hereditary predispositions to colorectal or endometrial cancer. Additionally, DiagMMR testing can be valuable in cases where traditional genetic testing methods have not provided conclusive results or in situations where timely diagnosis is essential for patient management.
How does Lynsight support healthcare providers in implementing DiagMMR testing into their clinical practice?
Lynsight works closely with healthcare providers to address any questions or concerns and optimize the use of DiagMMR testing for Lynch syndrome detection and management.
Save lives
with early detection
Healthcare professionals can confidently rely on DiagMMR as a trusted tool for Lynch syndrome detection and risk assessment. With its strong scientific foundation and extensive validation studies, DiagMMR has demonstrated exceptional performance in identifying individuals with Lynch syndrome and guiding personalized patient care.